Instrument-Free Point-of-Care Molecular Detection of Zika Virus
- PMID: 27306491
- PMCID: PMC4955015
- DOI: 10.1021/acs.analchem.6b01632
Instrument-Free Point-of-Care Molecular Detection of Zika Virus
Erratum in
-
Correction to "Instrument-Free Point-of-Care Molecular Detection of Zika Virus".Anal Chem. 2018 Nov 20;90(22):13814. doi: 10.1021/acs.analchem.8b04878. Epub 2018 Oct 31. Anal Chem. 2018. PMID: 30379066 Free PMC article. No abstract available.
Abstract
The recent outbreak of Zika virus (ZIKV) infection in the Americas and its devastating impact on fetal development have prompted the World Health Organization (WHO) to declare the ZIKV pandemic as a Public Health Emergency of International Concern. Rapid and reliable diagnostics for ZIKV are vital because ZIKV-infected individuals display no symptoms or nonspecific symptoms similar to other viral infections. Because immunoassays lack adequate sensitivity and selectivity and are unable to identify active state of infection, molecular diagnostics are an effective means to detect ZIKV soon after infection and throughout pregnancy. We report on a highly sensitive reverse-transcription loop-mediated, isothermal amplification (RT-LAMP) assay for rapid detection of ZIKV and its implementation in a simple, easy-to-use, inexpensive, point-of-care (POC) disposable cassette that carries out all the unit operations from sample introduction to detection. For thermal control of the cassette, we use a chemically heated cup without a need for electrical power. Amplification products are detected with leuco crystal violet (LCV) dye by eye without a need for instrumentation. We demonstrated the utility of our POC diagnostic system by detecting ZIKV in oral samples with sensitivity of 5 plaque-forming units (PFU) in less than 40 min. Our system is particularly suitable for resource-poor settings, where centralized laboratory facilities, funds, and trained personnel are in short supply, and for use in doctors' offices, clinics, and at home.
Conflict of interest statement
The authors declare no competing financial interest.
Figures
References
-
- Cao-Lormeau V. M.; Blake A.; Mons S.; Lastere S.; Roche C.; Vanhomwegen J.; Dub T.; Baudouin L.; Teissier A.; Larre P.; Vial A. L.; Decam C.; Choumet V.; Halstead S. K.; Willison H. J.; Musset L.; Manuguerra J. C.; Despres P.; Fournier E.; Mallet H. P.; Musso D.; Fontanet A.; Neil J.; Ghawche F. Lancet 2016, 387, 1531. 10.1016/S0140-6736(16)00562-6. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
